Annual EBITDA
-$43.43M$102.24M-173.84%
Summary
- Current Value
- As of today, GRDN annual EBITDA is -$43.43M, down -173.84% on
- Historical Performance
- GRDN annual EBITDA is down -193.41% over the past 3 years, and down -187.78% over the past 5 years
- All-Time High Comparison
- GRDN annual EBITDA is currently -163.72% below its historical high of $68.15M set on
- 3-Year Low Comparison
- GRDN annual EBITDA is at its 3-year low
- Sector Comparison
- GRDN annual EBITDA is higher than 33.22% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$43.43M | -173.8% | -193.4% | -187.8% | -213.4% | |
| Quarterly EBITDA | $22.67M | +122.8% | – | +743.2% | +268.0% | |
| TTM EBITDA | $80.91M | +280.5% | – | +275.3% | +1213.8% | |
| Price | $30.32 | +50.7% | – | – | – | |
| PE Ratio | 47.63 | – | – | – | – | |
| Annual Revenue | $1.23B | +17.4% | +55.1% | +75.9% | +104.6% | |
| Annual EPS | -$1.74 | -551.8% | -761.9% | -586.5% | -820.9% | |
| Annual EBIT | -$63.20M | -255.7% | -310.9% | -288.0% | -351.1% | |
| Annual Net Income | -$71.03M | -288.3% | -350.8% | -426.7% | -583.9% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $68.15M | N/A | -163.7% |
| 5Y | $68.15M | -163.7% | |
| All | $68.15M | -163.7% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$43.43M | at low | |
| 5Y | -$43.43M | at low | |
| All | -$43.43M | at low |
EBITDA History
| Year | Value | Change |
|---|---|---|
| -$43.43M | -173.8% | |
| $58.81M | -13.7% | |
| $68.15M | +46.6% | |
| $46.49M | -5.3% |
| Year | Value | Change |
|---|---|---|
| $49.07M | -0.8% | |
| $49.47M | +29.2% | |
| $38.31M | - |
FAQ
What is the current annual EBITDA of GRDN?
As of today, GRDN annual EBITDA is -$43.43M
What is 1-year change in GRDN annual EBITDA?
GRDN annual EBITDA is down -173.84% year-over-year
What is 3-year change in GRDN annual EBITDA?
GRDN annual EBITDA is down -193.41% over the past 3 years
How far is GRDN annual EBITDA from its all-time high?
GRDN annual EBITDA is currently -163.72% below its historical high of $68.15M set on December 1, 2022
How does GRDN annual EBITDA rank versus sector peers?
GRDN annual EBITDA is higher than 33.22% of companies in Healthcare sector
When is GRDN next annual earnings release?
The next annual earnings release for GRDN is on
Quarterly EBITDA
$22.67M$4.60M+25.44%
Summary
- Current Value
- As of today, GRDN quarterly EBITDA is $22.67M, up +25.44% on
- Historical Performance
- GRDN quarterly EBITDA is up +122.75% year-over-year, with unknown 3-year change
- All-Time High Comparison
- GRDN quarterly EBITDA is currently -23.73% below its historical high of $29.72M set on
- 3-Year Low Comparison
- GRDN quarterly EBITDA is +122.75% above its 3-year low of -$99.62M reached on
- Sector Comparison
- GRDN quarterly EBITDA is higher than 81.90% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $22.67M | +25.4% | +122.8% | – | +743.2% | |
| Annual EBITDA | -$43.43M | – | -173.8% | -193.4% | -187.8% | |
| TTM EBITDA | $80.91M | +295.6% | +280.5% | – | +275.3% | |
| Price | $30.32 | +28.0% | +50.7% | – | – | |
| PE Ratio | 47.63 | +28.0% | – | – | – | |
| Quarterly Revenue | $377.43M | +9.6% | +20.1% | – | +107.8% | |
| Quarterly EPS | $0.15 | +8.3% | +108.0% | – | +393.7% | |
| Quarterly EBIT | $16.83M | +33.8% | +116.1% | – | +5342.1% | |
| Quarterly Net Income | $9.59M | +8.7% | +109.1% | – | +399.3% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $22.67M | at high | |
| 3Y | $29.72M | -23.7% | |
| 5Y | $29.72M | -23.7% | |
| All | $29.72M | -23.7% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $18.07M | +25.4% | |
| 3Y | -$99.62M | +122.8% | |
| 5Y | -$99.62M | +122.8% | |
| All | -$99.62M | +122.8% |
Quarterly EBITDA History
| Month | Value | Change |
|---|---|---|
| $22.67M | +25.4% | |
| $18.07M | -1.1% | |
| $18.27M | -16.6% | |
| $21.91M | +122.0% | |
| -$99.62M | -555.3% |
| Month | Value | Change |
|---|---|---|
| $21.88M | +72.5% | |
| $12.68M | -37.3% | |
| $20.24M | +1,296.1% | |
| -$1.69M | -105.7% | |
| $29.72M | - |
FAQ
What is the current quarterly EBITDA of GRDN?
As of today, GRDN quarterly EBITDA is $22.67M
What is GRDN quarterly EBITDA most recent change?
GRDN quarterly EBITDA was up +25.44% on September 30, 2025
What is 1-year change in GRDN quarterly EBITDA?
GRDN quarterly EBITDA is up +122.75% year-over-year
How far is GRDN quarterly EBITDA from its all-time high?
GRDN quarterly EBITDA is currently -23.73% below its historical high of $29.72M set on June 1, 2023
How does GRDN quarterly EBITDA rank versus sector peers?
GRDN quarterly EBITDA is higher than 81.90% of companies in Healthcare sector
When is GRDN next earnings release?
The next earnings release for GRDN is on
TTM EBITDA
$80.91M$122.28M+295.59%
Summary
- Current Value
- As of today, GRDN TTM EBITDA is $80.91M, up +295.59% on
- Historical Performance
- GRDN TTM EBITDA is up +280.54% year-over-year, with unknown 3-year change
- All-Time High Comparison
- GRDN TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- GRDN TTM EBITDA is +280.54% above its 3-year low of -$44.82M reached on
- Sector Comparison
- GRDN TTM EBITDA is higher than 82.90% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $80.91M | +295.6% | +280.5% | – | +275.3% | |
| Annual EBITDA | -$43.43M | – | -173.8% | -193.4% | -187.8% | |
| Quarterly EBITDA | $22.67M | +25.4% | +122.8% | – | +743.2% | |
| Price | $30.32 | +28.0% | +50.7% | – | – | |
| PE Ratio | 47.63 | +28.0% | – | – | – | |
| TTM Revenue | $1.39B | +4.8% | +18.7% | – | +152.7% | |
| TTM EPS | $0.64 | +144.0% | +146.3% | – | +2990.3% | |
| TTM EBIT | $59.17M | +195.0% | +192.2% | – | +486.5% | |
| TTM Net Income | $39.53M | +152.1% | +157.9% | – | +3057.7% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $80.91M | at high | |
| 3Y | $80.91M | at high | |
| 5Y | $80.91M | at high | |
| All | $80.91M | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$43.15M | N/A | +287.5% |
| 3Y | -$44.82M | +280.5% | |
| 5Y | -$44.82M | +280.5% | |
| All | -$44.82M | +280.5% |
TTM EBITDA History
| Month | Value | Change |
|---|---|---|
| $80.91M | +295.6% | |
| -$41.37M | -10.1% | |
| -$37.56M | +13.0% | |
| -$43.15M | +3.7% | |
| -$44.82M | -184.4% |
| Month | Value | Change |
|---|---|---|
| $53.11M | -12.9% | |
| $60.95M | +26.3% | |
| $48.26M | +72.2% | |
| $28.03M | -5.7% | |
| $29.72M | - |
FAQ
What is the current TTM EBITDA of GRDN?
As of today, GRDN TTM EBITDA is $80.91M
What is GRDN TTM EBITDA most recent change?
GRDN TTM EBITDA was up +295.59% on September 30, 2025
What is 1-year change in GRDN TTM EBITDA?
GRDN TTM EBITDA is up +280.54% year-over-year
How far is GRDN TTM EBITDA from its all-time high?
GRDN TTM EBITDA is currently at its all-time high
How does GRDN TTM EBITDA rank versus sector peers?
GRDN TTM EBITDA is higher than 82.90% of companies in Healthcare sector
When is GRDN next earnings release?
The next earnings release for GRDN is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- GRDN Official Website guardianpharmacy.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1802255/000119312525274298/0001193125-25-274298-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1802255/000119312525064082/0001193125-25-064082-index.htm
- GRDN Profile on Yahoo Finance finance.yahoo.com/quote/GRDN
- GRDN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/grdn